These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 231297)

  • 21. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fecal flora of patients with Crohn's disease--fecal flora of untreated patients and changes caused by elemental diet].
    Suzuki K; Nagasaki A; Hiwatashi N; Goto Y
    Nihon Shokakibyo Gakkai Zasshi; 1983 May; 80(5):1144-50. PubMed ID: 6632320
    [No Abstract]   [Full Text] [Related]  

  • 23. Metronidazole for Crohn's disease.
    Ursing B; Kamme C
    Lancet; 1975 Apr; 1(7910):775-7. PubMed ID: 48003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J; Schuster MM
    Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metronidazole. A therapeutic review and update.
    Freeman CD; Klutman NE; Lamp KC
    Drugs; 1997 Nov; 54(5):679-708. PubMed ID: 9360057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.
    Favier C; Neut C; Mizon C; Cortot A; Colombel JF; Mizon J
    Dig Dis Sci; 1997 Apr; 42(4):817-22. PubMed ID: 9125655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of metronidazole (Flagyl) in Crohn's disease.
    Babb RR
    J Clin Gastroenterol; 1988 Oct; 10(5):479-81. PubMed ID: 3053871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Crohn's disease with metronidazole (author's transl)].
    Schneider MU; Strobel S; Riemann JF; Demling L
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1126-9. PubMed ID: 6114847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the duodenal and fecal flora in gastrointestinal disorders during treatment with an elemental diet.
    Axelsson CK; Justesen T
    Gastroenterology; 1977 Mar; 72(3):397-401. PubMed ID: 832786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healing of perineal Crohn's disease with metronidazole.
    Bernstein LH; Frank MS; Brandt LJ; Boley SJ
    Gastroenterology; 1980 Aug; 79(2):357-65. PubMed ID: 7399243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination ciprofloxacin and metronidazole for active Crohn's disease.
    Greenbloom SL; Steinhart AH; Greenberg GR
    Can J Gastroenterol; 1998; 12(1):53-6. PubMed ID: 9544412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.
    Levine A; Kori M; Kierkus J; Sigall Boneh R; Sladek M; Escher JC; Wine E; Yerushalmi B; Amil Dias J; Shaoul R; Veereman Wauters G; Boaz M; Abitbol G; Bousvaros A; Turner D
    Gut; 2019 Feb; 68(2):239-247. PubMed ID: 29420227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection and the use of antibiotics in Crohn's disease.
    Keighley MR
    Can J Surg; 1984 Sep; 27(5):438-41. PubMed ID: 6383583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
    Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
    Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic Crohn's disease responding to metronidazole.
    Duhra P; Paul CJ
    Br J Dermatol; 1988 Jul; 119(1):87-91. PubMed ID: 3408668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group.
    Peach S; Lock MR; Katz D; Todd IP; Tabaqchali S
    Gut; 1978 Nov; 19(11):1034-42. PubMed ID: 730070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the immune response to aerobic and anaerobic intestinal bacteria in a patient with Crohn's disease.
    Danielsson D; Kjellander J; Persson S; Wallensten S
    Scand J Infect Dis Suppl; 1979; (19):52-60. PubMed ID: 223235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fecal flora of man. V. communication: The fluctuation of the fecal flora of the healthy adult (author's transl)].
    Mitsuoka T; Ono K
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):228-36. PubMed ID: 196456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of antimicrobials in Crohn's disease.
    Kale-Pradhan PB; Zhao JJ; Palmer JR; Wilhelm SM
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):281-8. PubMed ID: 23445237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perineal Crohn's disease complicated by pyogenic liver abscess during metronidazole therapy.
    Hatoff DE
    Gastroenterology; 1983 Jul; 85(1):194-5. PubMed ID: 6852451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.